To unveil the necroptotic status in HNSCC, we first assessed the expression of phospho-MLKL, which is currently the most recognized marker for necroptosis, in tumor and tumor-adjacent epithelial tissues (TAE) of HNSCC patients. This evidence concerns the gene MLKL and neoplasm.